149 related articles for article (PubMed ID: 21865669)
1. Combination of preS deletions and A1762T/G1764A mutations in HBV subgenotype C2 increases the risk of developing HCC.
Lee MH; Kim DY; Kim JK; Chang HY; Kang SH; Ryu HJ; Ju HL; Kim SU; Lee JM; Park JY; Han KH; Chon CY; Ahn SH
Intervirology; 2012; 55(4):296-302. PubMed ID: 21865669
[TBL] [Abstract][Full Text] [Related]
2. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
3. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM
Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434
[TBL] [Abstract][Full Text] [Related]
4. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.
Yin J; Zhang H; He Y; Xie J; Liu S; Chang W; Tan X; Gu C; Lu W; Wang H; Bi S; Cui F; Liang X; Schaefer S; Cao G
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):777-86. PubMed ID: 20160279
[TBL] [Abstract][Full Text] [Related]
5. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
[TBL] [Abstract][Full Text] [Related]
6. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
[TBL] [Abstract][Full Text] [Related]
8. Combined core promoter mutations and pre-S deletion of HBV may not increase the risk of HCC: a geographical epidemiological study in Guangxi, China.
Li GJ; Harrison TJ; Yang JY; Chen QY; Wang XY; Fang ZL
Liver Int; 2013 Jul; 33(6):936-43. PubMed ID: 23517325
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.
Xiao L; Zhou B; Gao H; Ma S; Yang G; Xu M; Abbott WG; Chen J; Sun J; Wang Z; Hou J
J Med Virol; 2011 Sep; 83(9):1544-50. PubMed ID: 21739444
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C.
Mun HS; Lee SA; Jee Y; Kim H; Park JH; Song BC; Yoon JH; Kim YJ; Lee HS; Hyun JW; Hwang ES; Kook YH; Kim BJ
J Med Virol; 2008 Jul; 80(7):1189-94. PubMed ID: 18461612
[TBL] [Abstract][Full Text] [Related]
12. Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.
Jang JW; Chun JY; Park YM; Shin SK; Yoo W; Kim SO; Hong SP
Cancer Sci; 2012 Feb; 103(2):296-304. PubMed ID: 22136288
[TBL] [Abstract][Full Text] [Related]
13. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
[TBL] [Abstract][Full Text] [Related]
14. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea.
Song BC; Kim H; Kim SH; Cha CY; Kook YH; Kim BJ
J Med Virol; 2005 Jan; 75(1):13-9. PubMed ID: 15543574
[TBL] [Abstract][Full Text] [Related]
15. Genetic variability of hepatitis B and C viruses in Brazilian patients with and without hepatocellular carcinoma.
Araujo OC; Barros JJ; do Ó KM; Nabuco LC; Luz CA; Perez RM; Niel C; Villela-Nogueira CA; Araujo NM
J Med Virol; 2014 Feb; 86(2):217-23. PubMed ID: 24338810
[TBL] [Abstract][Full Text] [Related]
16. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
[TBL] [Abstract][Full Text] [Related]
17. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
[TBL] [Abstract][Full Text] [Related]
18. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients.
Yan CH; Zhao CY; Ding H; Peng YQ; Jin PY; Yan L; Zhuang H; Li T
Antiviral Res; 2012 Nov; 96(2):108-14. PubMed ID: 22960603
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease.
Puche ML; Kay-Valero S; Michelli P; Oropeza MD; Loureiro CL; Devesa M; Dagher L; Pujol FH
Invest Clin; 2016 Mar; 57(1):38-46. PubMed ID: 27382800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
